Obermatt
See Similar Stocks →

Canopy Growth

TOR:WEED · CA1380357048
PharmaceuticalsSmall

360

19
Profit price48
Owner Earnings Yield1
Dividend Yield1
Price/Sales74
EV / Gross Profit25
Price/Book74
Return on Capital39
Cash Return on Capital23
Return on Equity23
EBIT Margin12
Gross Profitability22
Accruals89
Owner Earnings Margin24
Sales growth55
Profit growth39
Reinvestment4
Price momentum20
Debt load46
Refinancing82
Debt Payback1
Liquidity42
Analyst ratings9
Opinion Changes17
Price Target Upside25
Market mood1
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Canopy Growth doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryCanada
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeTSX
Employees556
Websitecanopygrowth.com
ISINCA1380357048
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
CannabisAlternative MedicineHealth CareMedicalPharmaceutical

Description

Canopy Growth Corporation (Canopy Growth), a cannabis company, produces, distributes, and sells a diverse range of cannabis and cannabis-related products. The company’s core operations are in Canada, Germany, and Australia, and the company holds a s…

Analysis

Middle-of-the-road

Canopy Growth Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is stretched. The company scores 6/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
20
2023202420252026

All-time high

77

Jan 2023

All-time low

4

Jan 2024

Average rank

33

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
74
60
72
34
Price/Earnings
89
—
—
—
Price/Book
74
83
13
90
Dividend Yield
1
1
1
1
Value (overall)
79
75
40
67

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Canopy Growth with its peers
Cronos Group
TOR:CRON
45
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Tilray Brands
NSQ:TLRY
18
CountryCanada
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
High Tide
CVE:HITI
62
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Trulieve Cannabis
CNX:TRUL
39
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
SNDL
NAQ:SNDL
45
CountryCanada
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Aurora Cannabis
TOR:ACB
34
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →